Tell Congress: Ask Mylan CEO Heather Bresch Tough Questions

As the price of EpiPens skyrocketed, so did the salary of Heather Bresch, the CEO of the company that makes the pocket-sized device – up to nearly $19 million.

In fact, executive payouts at Mylan are the second-highest among Big Pharma companies. In the past five years, Mylan has paid its top five executives nearly $300 million.

No wonder these executives are out of touch with the fact that many people who could die without an EpiPen can’t afford one.

Now we must insist that Congress ask the tough questions.

Sign the Petition to Congress

When Mylan CEO Heather Bresch testifies, don’t back down from the tough questions. Ask Bresch about price gouging and bloated executive payouts!